Evidence Health
← Search another medicinePrintable summary →

Meclizine Hydrochloride Chewable

Also sold as Meclizine HCl

From 1 official FDA drug label · RxNorm 995632

This comes from U.S. FDA labels. Brand names, strengths and advice can differ in your country; check with a local health professional. Set your country.

What it is used for

These are the uses the FDA has approved for this label. Using it for anything else is “off-label”: ask your prescriber why.

Uses prevents and treats nausea, vomiting or dizziness due to motion sickness.

How to take it

Directions Dosage should be taken one hour before travel starts Adults and children 12 years and older: Chew 1-2 tablets once daily, or as directed by a doctor Children under 12 years: do not give this product to children under 12 years of age unless directed by a doctor

Ask a doctor or pharmacist before using it if

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

Serious warnings and precautions

Warnings Do not use in children under 12 years of age unless directed by a doctor Ask a doctor before use if you have glaucoma a breathing problem such as emphysema or chronic bronchitis trouble urinating due to an enlarged prostate gland

When using this product

When using this product may cause drowsiness alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic drinks use caution when driving a motor vehicle or operating machinery

If you are pregnant or breastfeeding

If pregnant or breast-feeding , ask a health professional before use.

Keep out of reach of children

Keep out of reach of children. In case of overdose, get medical help or contact the Poison Control Center immediately.

Forms and strengths available

25 MG · Disintegrating Oral Tablet50 MG · Chewable Tablet12.5 MG · Oral Tablet25 MG · Chewable Tablet25 MG · Oral Tablet30 MG · Oral Tablet50 MG · Oral Tablet

From RxNorm. Which forms and strengths are actually stocked varies by pharmacy and country.

Reactions people have reported

diarrhoea 3haemoglobin decreased 3bronchitis 2abdominal pain 2dizziness 2white blood cell count decreased 1hypersensitivity 1chronic obstructive pulmonary disease 1asthenia 1rhinitis allergic 1

These are counts from 11 voluntary reports to the FDA. They show what has been reported — they are not how common a side effect is, and they do not prove the medicine caused it.

Recalls

Class II · Apr 1, 2026
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Reason: Failed tablet specifications.
Class II · Jun 15, 2022
Meclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cards per carton, Rx only, MFG: Avkare Inc., NDC 50268-523-15
Reason: cGMP deviations: Temperature abuse
Class I · Apr 6, 2022
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Reason: Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
Class III · Nov 20, 2019
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
Reason: Subpotent Drug
Class III · Nov 20, 2019
WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,
Reason: Subpotent Drug
Class III · Nov 22, 2017
Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06
Reason: Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

Research & studies

Recent higher-quality studies about Meclizine Hydrochloride Chewable, from PubMed. We link to the source — titles only. This is not medical advice.

ReviewEfficacy and safety of tradipitant in motion sickness: a systematic review and meta-analysis.Acta neurologica Belgica · 2026 Aug 12ReviewPromising horizons in achondroplasia along with the development of new drugs.Endocrine journal · 2024 Jul 12ReviewImportance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting α-synuclein and neuroprotection in the treatment of Parkinson's disease.Revue neurologique · 2024 OctReviewUnderstanding flow chemistry for the production of active pharmaceutical ingredients.iScience · 2022 Mar 18Meta-AnalysisSystems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.Archives of biochemistry and biophysics · 2022 Jan 15Systematic ReviewDrugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.The Cochrane database of systematic reviews · 2020 Oct 19

Similar medicines

Meclizine Hydrochloride Chewable belongs to the Piperazine derivatives class. Other medicines in it:

cetirizine

Questions to ask your doctor or pharmacist

Why you can trust this

Everything above comes from official FDA drug labels (openFDA), not written by us. Here are the exact labels used.

This information explains the official label. It cannot tell you whether this medicine is right or safe for you personally — only a qualified health professional who knows your history can do that. Do not start, stop, or change a medicine based on this page alone.